Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980;71(1):121–134. doi: 10.1111/j.1476-5381.1980.tb10917.x

Interaction of selective α-adrenoceptor agonists and antagonists with human and rabbit blood platelets

Jacqueline A Grant, Michael C Scrutton
PMCID: PMC2044410  PMID: 6110451

Abstract

1 The selectivity of α-adrenoceptors mediating the pro-aggregatory response of human and rabbit platelets to adrenaline and the conditions required to permit expression of an aggregatory response to partial agonists at these α-adrenoceptors have been studied.

2 Yohimbine causes effective blockade of the pro-aggregatory responses whereas indoramin and prazosin are ineffective.

3 The clonidine analogue, UK-14304, is nearly as effective as adrenaline in inducing an aggregatory response in human platelets and a pro-aggregatory response in rabbit platelets. Cross-tachyphylaxis between adrenaline and UK-14304 has been demonstrated.

4 Clonidine is a weak agonist for the pro-aggregatory response of rabbit platelets and in some donors for the aggregatory response of human platelets.

5 Methoxamine induces a pro-aggregatory response in human platelets which is blocked by indoramin or prazosin but not by yohimbine. No such response to methoxamine is observed in rabbit platelets.

6 The divalent cation ionophore, A-23187, induces an aggregatory response to clonidine (in platelets from a non-responsive donor), phenylephrine and methoxamine in human platelets and to adrenaline, UK-14304 and clonidine in rabbit platelets. A secretory response to clonidine is also induced by A-23187 in human platelets.

7 The adenylate cyclase inhibitor, SQ-22536, is ineffective in either inducing a response to the α-agonists or potentiating the effect of A-23187.

8 The aggregatory responses to adrenaline and UK-14304 in rabbit platelets and to clonidine in human and rabbit platelets, which can be induced by A-23187, are blocked by yohimbine but not by prazosin or indoramin.

9 From these studies we conclude that the pro-aggregatory responses of human and rabbit platelets to adrenaline are mediated primarily by α2-adrenoceptors. The presence of α1-adrenoceptors on human platelets is confirmed but these receptors do not appear to be present on rabbit platelets. The conditions required for expression of an aggregatory response to partial agonists at the human and rabbit platelet α-adrenoceptors implicate an increase in cytosolic Ca2+ concentration as a key event in stimulus-response coupling but do not indicate such a role for depression of cyclic adenosine-3′,5′-monophosphate concentration.

Full text

PDF
121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ardlie N. G., Glew G., Schwartz C. J. Influence of catecholamines on nucleotide-induced platelet aggregation. Nature. 1966 Oct 22;212(5060):415–417. doi: 10.1038/212415a0. [DOI] [PubMed] [Google Scholar]
  2. Ashton H., Rawlins M. D. Central nervous system depressant actions of clonidine and UK-14,304: partial dissociation of EEG and behavioural effects. Br J Clin Pharmacol. 1978 Feb;5(2):135–140. doi: 10.1111/j.1365-2125.1978.tb01614.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bremner R. M., Greengrass P. M. Regional variations in [3H]-prazosin and [3H]-noradrenaline binding in the rat brain [proceedings]. Br J Pharmacol. 1979 May;66(1):153P–153P. [PMC free article] [PubMed] [Google Scholar]
  4. Brown D. A., Caulfield M. P. Hyperpolarizing 'alpha 2'-adrenoceptors in rat sympathetic ganglia. Br J Pharmacol. 1979 Mar;65(3):435–445. doi: 10.1111/j.1476-5381.1979.tb07848.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chan T. M., Exton J. H. alpha-Adrenergic-mediated accumulation of adenosine 3':5' monophosphate in calcium-depleted hepatocytes. J Biol Chem. 1977 Dec 10;252(23):8645–8651. [PubMed] [Google Scholar]
  6. Costa J. L., Murphy D. L. Platelet 5-HT uptake and release stopped rapidly by formaldehyde. Nature. 1975 May 29;255(5507):407–408. doi: 10.1038/255407a0. [DOI] [PubMed] [Google Scholar]
  7. Doxey J. C., Smith C. F., Walker J. M. Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors. Br J Pharmacol. 1977 May;60(1):91–96. doi: 10.1111/j.1476-5381.1977.tb16752.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Drew G. M. Effects of alpha-adrenoceptor agonists and antagonists on pre- and postsynaptically located alpha-adrenoceptors. Eur J Pharmacol. 1976 Apr;36(2):313–320. doi: 10.1016/0014-2999(76)90084-4. [DOI] [PubMed] [Google Scholar]
  9. Drew G. M. Pharmacological characterization of the presynaptic alpha-adrenoceptors regulating cholinergic activity in the guinea-pig ileum. Br J Pharmacol. 1978 Oct;64(2):293–300. doi: 10.1111/j.1476-5381.1978.tb17303.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Egan C. M., Fisher A. P., Scrutton M. C. Factors influencing the response of human blood platelets to analogues of ADP which may act as partial agonists at the ADP receptor. Eur J Biochem. 1979 Mar 15;95(1):127–137. doi: 10.1111/j.1432-1033.1979.tb12947.x. [DOI] [PubMed] [Google Scholar]
  11. Feinman R. D., Detwiler T. C. Platelet secretion induced by divalent cation ionophores. Nature. 1974 May 10;249(453):172–173. doi: 10.1038/249172a0. [DOI] [PubMed] [Google Scholar]
  12. Grant J. A., Scrutton M. C. Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation. Nature. 1979 Feb 22;277(5698):659–661. doi: 10.1038/277659a0. [DOI] [PubMed] [Google Scholar]
  13. Haslam R. J. Roles of cyclic nucleotides in platelet function. Ciba Found Symp. 1975;35:121–151. doi: 10.1002/9780470720172.ch7. [DOI] [PubMed] [Google Scholar]
  14. Hoffman B. B., De Lean A., Wood C. L., Schocken D. D., Lefkowitz R. J. Alpha-adrenergic receptor subtypes: quantitative assessment by ligand binding. Life Sci. 1979 May 7;24(19):1739–1745. doi: 10.1016/0024-3205(79)90061-4. [DOI] [PubMed] [Google Scholar]
  15. Hsu C. Y., Knapp D. R., Halushka P. V. The effects of alpha adrenergic agents on human platelet aggregation. J Pharmacol Exp Ther. 1979 Mar;208(3):366–370. [PubMed] [Google Scholar]
  16. Jakobs K. H., Saur W., Schultz G. Characterization of alpha- and beta-adrenergic receptors linked to human platelet adenylate cyclase. Naunyn Schmiedebergs Arch Pharmacol. 1978 May;302(3):285–291. doi: 10.1007/BF00508297. [DOI] [PubMed] [Google Scholar]
  17. Jakobs K. H. Synthetic alpha-adrenergic agonists are potent alpha-adrenergic blockers in human platelets. Nature. 1978 Aug 24;274(5673):819–820. doi: 10.1038/274819a0. [DOI] [PubMed] [Google Scholar]
  18. Langer S. Z. Presynaptic regulation of catecholamine release. Biochem Pharmacol. 1974 Jul 1;23(13):1793–1800. doi: 10.1016/0006-2952(74)90187-7. [DOI] [PubMed] [Google Scholar]
  19. Lasch P., Jakobs K. H. Agonistic and antagonistic effects of various alpha-adrenergic agonists in human platelets. Naunyn Schmiedebergs Arch Pharmacol. 1979 Mar;306(2):119–125. doi: 10.1007/BF00498981. [DOI] [PubMed] [Google Scholar]
  20. Medgett I. C., McCulloch M. W., Rand M. J. Partial agonist of clonidine on prejunctional and postjunctional alpha-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1978 Oct;304(3):215–221. doi: 10.1007/BF00507961. [DOI] [PubMed] [Google Scholar]
  21. Mills D. C., Smith J. B. The control of platelet responsiveness by agents that influence cyclic AMP metabolism. Ann N Y Acad Sci. 1972 Oct 27;201:391–399. doi: 10.1111/j.1749-6632.1972.tb16312.x. [DOI] [PubMed] [Google Scholar]
  22. Newman K. D., Williams L. T., Bishopric N. H., Lefkowitz R. J. Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding. J Clin Invest. 1978 Feb;61(2):395–402. doi: 10.1172/JCI108950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pearce P. H., Wright J. M., Egan C. M., Scrutton M. C. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate. Eur J Biochem. 1978 Aug 1;88(2):543–554. doi: 10.1111/j.1432-1033.1978.tb12480.x. [DOI] [PubMed] [Google Scholar]
  24. Salzman E. W. Prostaglandins and platelet function. Adv Prostaglandin Thromboxane Res. 1976;2:767–780. [PubMed] [Google Scholar]
  25. Scrutton M. C., Grant J. A. Dihydroergocryptine is a non-selective antagonist for human platelet alpha-adrenoreceptors. Nature. 1979 Aug 23;280(5724):700–700. doi: 10.1038/280700a0. [DOI] [PubMed] [Google Scholar]
  26. Skolnick P., Daly J. W. Stimulation of adenosine 3',5'-monophosphate formation by alpha and beta adrenergic agonists in rat cerebral cortical slices: effects of clonidine. Mol Pharmacol. 1975 Sep;11(5):545–551. [PubMed] [Google Scholar]
  27. Starke K., Endo T., Taube H. D. Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol. 1975;291(1):55–78. doi: 10.1007/BF00510821. [DOI] [PubMed] [Google Scholar]
  28. Wallis R. B. The role of prostaglandins in the ADP-induced aggregation of rabbit platelets shown by the use of 15-hydroxyprostaglandin dehydrogenase. Thromb Haemost. 1978 Jun 30;39(3):725–732. [PubMed] [Google Scholar]
  29. Wikberg J. E. Pharmacological classification of adrenergic alpha receptors in the guinea pig. Nature. 1978 May 11;273(5658):164–166. doi: 10.1038/273164a0. [DOI] [PubMed] [Google Scholar]
  30. Wood C. L., Arnett C. D., Clarke W. R., Tsai B. S., Lefkowitz R. J. Subclassification of alpha-adrenergic receptors by direct binding studies. Biochem Pharmacol. 1979 Apr 15;28(8):1277–1282. doi: 10.1016/0006-2952(79)90424-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES